Men's Health Supplement

Super Beta Virility Boost

145 adverse event reports submitted to the FDA · 2016–2019 · Data current as of June 3, 2026

These are reports submitted to the FDA. A report does not mean the product caused the effect. Counts reflect reporting activity, not how common an effect is.

Most Reported Reactions

Top 10 reactions from 145 reports. One report may include multiple reactions — reaction totals may exceed the report count.

Blood urine present

Haematochezia

Dyspnoea

Blood pressure increased

Urinary retention

Cerebrovascular accident

Hypertension

Chest pain

Dizziness

Haemorrhage

Reported Outcomes

Outcome categories as recorded in FDA reports. One report may include multiple outcomes.

Outcome	Reports
Other Serious or Important Medical Event	109
Other Serious Outcome	44
Hospitalization	33
Visited Emergency Room	19
Visited a Health Care Provider	18
Death	1

Who Reported

Reporter demographics where available. Many reports do not include age or gender data.

Age

Under 18

18–34

35–49

50–64

65–79

80+

Unknown

66 reports had age data; 79 unknown.

Gender

Male

132

Unknown/Not Reported

Reports by Year

Annual report counts from 2016–2019. Spike years may reflect recalls, media coverage, or litigation rather than changes in the product.

'16

'17

'18

'19

Hover bars for exact counts.

Context about this data: Reports concentrated in 2017–2018, likely reflecting launch-period adverse event collection for a new product line.

← View all Super Beta products in FDA data

Data Source

This page presents data from the FDA's CFSAN Adverse Event Reporting System (CAERS) via the openFDA API. Reports are voluntary and unverified. The FDA has not concluded that this product caused any reported event.

View openFDA CAERS data ↗ · About our methodology · How to read this data